GlobeNews Wire

AJA Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements

July 08, 2025 16:48 ET  | Source: Aja Health and Wellness Inc. Not for dissemination in the United States of…

12 months ago

UAE Approves BioAros Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant move that bridges biotechnology, preventive health, and global wellness…

12 months ago

AB Science announces the successful completion of a EUR 1.925 million private placement

PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am…

12 months ago

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a…

12 months ago

Diginex Announces Plans for Eight-for-One Forward Stock Split

July 07, 2025 23:29 ET  | Source: Diginex Limited LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or…

12 months ago

NIOs firefly brand taps HERE Technologies to power smart, connected EV journeys

firefly will use HERE’s high-quality map data in global markets to enhance advanced driver assistance and safety functions, including Intelligent…

12 months ago

Ripple’s national license is imminent, and RICH Miner helps XRP investors create higher real value

New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- Ripple (XRP) is gradually getting rid of the regulatory shadow…

12 months ago

UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

12 months ago

LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net…

12 months ago

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

July 07, 2025 08:00 ET  | Source: KALA BIO, Inc. ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO,…

12 months ago